Home Page

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE ?UNITED STATES

CINCINNATI, Ohio, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: ?PTQ), a healthcare services company with operations in the United States, is pleased to report that it has successfully received a final Garnishee Order Absolute from the Court in Hong Kong as was contemplated in the Company’s news release dated June 26, 2019. Accordingly, it is expected that the bank will release to the Company the CAD$8.6 million which the Company had frozen in the perpetrator’s bank account.

It is expected, and it would be customary, that the bank will release the funds to the Company within 2-3 weeks of receipt of the Order, which should be achieved in the next 10 days. Additional information will be released by the Company as it becomes available.?

“I am extremely pleased to have received this court order and look forward to having the moneys returned to the Company,” said Greg Crawford, the Company’s CEO and Chairman.

ABOUT PROTECH HOME MEDICAL CORP.?

The Company provides in-home monitoring and disease management services for patients in the ?United States healthcare market. The primary business objective of the Company is to create shareholder ?value by offering a broader range of services to patients in need of in-home monitoring and chronic ?disease management. The Company’s organic growth strategy is to increase annual revenue per ?patient by offering multiple services to the same patient, consolidating the patient’s services and ?making life easier for the patient. ?

Forward-Looking Statements

Certain statements contained in this press release constitute "forward-looking information" as such ?term is defined in applicable Canadian securities legislation. The words "may", "would", "could",?? "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and ?similar expressions as they relate to the Company, including: the timelines indicated herein; and the bank releasing the funds pursuant to the order of the Hong Kong Court; are intended to identify ?forward-looking information. All statements other than statements of historical fact may be forward-?looking information. Such statements reflect the Company's current views and intentions with respect ?to future events, and current information available to the Company, and are subject to certain risks, ?uncertainties and assumptions, including, without limitation: the Hong Kong Court and bank following customary timelines and the bank complying with the order of the Hong Kong Court. Many factors could ?cause the actual results, performance or achievements that may be expressed or implied by such ?forward-looking information to vary from those described herein should one or more of these risks or ?uncertainties materialize. Examples of such risk factors include, without limitation: credit; market ??(including equity, commodity, foreign exchange and interest rate); liquidity; operational (including ?technology and infrastructure); reputational; insurance; strategic; regulatory; legal; environmental; ?capital adequacy; the general business and economic conditions in the regions in which the Company ?operates; the ability of the Company to execute on key priorities, including the successful completion ?of acquisitions, business retention, and strategic plans and to attract, develop and retain key ?executives; difficulty integrating newly acquired businesses; the ability to implement business ?strategies and pursue business opportunities; low profit market segments; disruptions in or attacks ??(including cyber-attacks) on the Company's information technology, internet, network access or other ?voice or data communications systems or services; the evolution of various types of fraud or other ?criminal behavior to which the Company is exposed; the failure of third parties to comply with their ?obligations to the Company or its affiliates; the impact of new and changes to, or application of, ?current laws and regulations; decline of reimbursement rates; dependence on few payors; possible ?new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and ?licenses in a highly regulated business; the overall difficult litigation environment, including in the U.S.; ?increased competition; changes in foreign currency rates; increased funding costs and market volatility ?due to market illiquidity and competition for funding; the availability of funds and resources to pursue ?operations; critical accounting estimates and changes to accounting standards, policies, and methods ?used by the Company; and the occurrence of natural and unnatural catastrophic events and claims ?resulting from such events; as well as those risk factors discussed or referred to in the Company’s ?disclosure documents filed with the securities regulatory authorities in certain provinces of Canada and ?available at www.sedar.com. Should any factor affect the Company in an unexpected manner, or ?should assumptions underlying the forward-looking information prove incorrect, the actual results or ?events may differ materially from the results or events predicted. Any such forward-looking ?information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company ?does not assume responsibility for the accuracy or completeness of such forward-looking information. ?The forward-looking information included in this press release is made as of the date of this press ?release and the Company undertakes no obligation to publicly update or revise any forward-looking ?information, other than as required by applicable law.?

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information please visit our website at www.protechhomemedical.com or contact:?

Gregory Crawford
Chief Executive Officer
Protech Home Medical Corp.?
?859-300-6455?
investorinfo@myphm.com

Media Enquiries:?
PHM.communications@strategycorp.com